You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BCR-ABL Positive (BCR-ABL )

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Landscape and Real-life Treatment Outcomes in Hungary: Analysis

Completed
  • Chronic Myeloid Leukaemia
  • Budapest, Hungary
    Pfizer
Dec 15, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Rochester (Hyperbaric oxygen)

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Hyperbaric oxygen
  • Rochester, New York
    Wilmot Cancer Institute, University of Rochester
May 16, 2022

New Diagnosed Chronic Phase Chronic Myeloid Leukemia

Recruiting
  • Validity and Safety
    • Guangzhou, Guangdong, China
      NanfangH
    Apr 9, 2022

    Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,

    Active, not recruiting
    • Acute Biphenotypic Leukemia
    • +18 more
    • Aurora, Colorado
    • +2 more
    Dec 28, 2022

    Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Dasatinib Pill
    • Ketoconazole Pill
    • Monterrey, Nuevo Leon, Mexico
      Hospital Universitario Dr. José Eleuterio González
    Nov 25, 2022

    Treatment Free Remission (TFR) in CML Patients (CML-CP)Study

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Treatment-free Remission
    • TFR(Treatment-Free Remission)
    • (no location specified)
    Jun 27, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia With

    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +5 more
    • Blinatumomab
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 1, 2022

    Condition Vasoregulation Function Endothelium in CML Getting TKI

    Recruiting
    • Chronic Myeloid Leukaemia
    • taking blood for the study of biochemical parameters and the study of microcirculation using the method of laser Doppler flowmetry
    • Moscow, Russian Federation
    • +1 more
    Jan 11, 2023

    3L+ Therapies Among Chronic Myeloid Leukemia and Those With

    Completed
    • Chronic Myeloid Leukemia
      • East Hanover, New Jersey
        Novartis Investigative Site
      Nov 11, 2022

      Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

      Recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • +3 more
      • Augusta, Georgia
      • +1 more
      Jul 14, 2022

      CML (Chronic Myelogenous Leukemia Trial (KDS-1001)

      Not yet recruiting
      • CML (Chronic Myelogenous Leukemia
      • (no location specified)
      Jul 27, 2022

      Effect of Pharmacogenetics on Imatinib Plasma Level and Response

      Active, not recruiting
      • Chronic Myeloid Leukemia
      • PCR
      • HPLC-UV
      • Assiut, Egypt
        South Egypt Cancer Institute
      Aug 6, 2022

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

      Not yet recruiting
      • Acute Lymphoblastic Leukemia
      • +6 more
      • Miltenyi CliniMACS Prodigy ® system
      • (no location specified)
      Mar 23, 2023

      Study Conducted Among Patients With CML

      Completed
      • Chronic Myeloid Leukemia
      • Tyrosine Kinase Inhibitors (TKIs)
      • East Hanover, New Jersey
        Novartis Investigative Site
      Jul 25, 2022

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

      Not yet recruiting
      • Acute Lymphoblastic Leukemia
      • +9 more
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • +7 more
      • Duarte, California
      • +1 more
      Sep 22, 2023

      Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

      Recruiting
      • Chronic Myeloid Leukemia in Myeloid Blast Crisis
      • +3 more
      • based decitabine and olverembatinib（HQP1351)chemotherapy
      • Guanzhou, China
        Department of Hematology, Nanfang Hospital, Southern Medical Uni
      Dec 6, 2022

      Chronic Myeloid Leukaemia Recurrent, Chronic Myeloid Leukemia, in Relapse Trial in Huixquilucan (Myeloid mutations measurement)

      Recruiting
      • Chronic Myeloid Leukaemia Recurrent
      • Chronic Myeloid Leukemia, in Relapse
      • Myeloid mutations measurement
      • Huixquilucan, Estado De México, Mexico
        Grupo Cooperativo de Hemopatías Malignas
      Oct 4, 2021

      Chronic Myelogenous Leukemia Trial in Beirut (Nilotinib)

      Recruiting
      • Chronic Myelogenous Leukemia
      • Beirut, Lebanon
        American University of Beirut Medical Center
      Feb 14, 2022

      Among CP-CML Participants Initiating Dasatinib inReal Life

      Completed
      • Chronic Myeloid Leukemia
      • Non-Interventional
      • Paris, France
        Local Institution
      Jun 17, 2022

      Chronic Myeloid Leukemia in Chronic Phase Trial in Belgium, Germany (LBH589)

      Terminated
      Has Results
      • Chronic Myeloid Leukemia in Chronic Phase
      • Bruxelles, Belgium
      • +9 more
      Jul 14, 2021

      Leukemia, Myelodysplastic Syndrome, Non-Hodgkins Lymphoma Trial in New York (fludarabine, cyclophosphamide, thiotepa, radiation

      Completed
      Has Results
      • Leukemia
      • +4 more
      • fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Nov 10, 2022

      TKI Discontinuation in CML Patients of China

      Recruiting
      • Leukemia
      • +4 more
        • Shenzhen, Guangdong, China
          Shenzhen Second People's Hospital
        Mar 15, 2022

        Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca Trial run by the National Heart, Lung, and Blood Institute

        Completed
        • Chronic Myeloid Leukemia (CML)
        • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Dec 31, 2022

        Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid

        Active, not recruiting
        • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • +12 more
        • Laboratory Biomarker Analysis
        • +2 more
        • Duarte, California
        • +2 more
        Feb 17, 2022

        Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Chronic Conditions Trial in Ann Arbor (Patient Reported Outcome

        Terminated
        • Chronic Myeloid Leukemia
        • +2 more
        • Patient Reported Outcome Measure (PROM)
        • +2 more
        • Ann Arbor, Michigan
          University of Michigan Rogel Cancer Center
        Nov 21, 2022